Log In
BCIQ
Print this Print this
 

Qsiva, Qsivia, Qsymia, phentermine/topiramate (VI-0521) (formerly Qnexa)

  Manage Alerts
Collapse Summary General Information
Company Vivus Inc.
DescriptionLow-dose combination of phentermine and topiramate
Molecular Target Not available
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule: Combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$640.0M

$640.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/25/2014

Undisclosed

Undisclosed

0

05/28/2014

$640.0M

$640.0M

0

Get a free BioCentury trial today